Stocks
DexCom, Inc.DXCM
NASDAQHealthcareMedical Devices$64.24-1.56%
Specializing in continuous glucose monitoring systems, this company is a leader in diabetes care technology. Its innovative devices provide real-time glucose readings, reducing the need for traditional fingerstick tests. Investors closely monitor its growth due to its strong market position and the increasing global prevalence of diabetes.
Market Cap: $25.1B52W Range: $54.11 – $89.98
Congressional Interest in DexCom, Inc. (DXCM)
14 members of Congress have disclosed 50 trades in DexCom, Inc. (DXCM), a Healthcare company. The buy/sell breakdown shows 18 purchases versus 32 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
14
Buys
18
Sells
32
Who in Congress Is Trading DXCM?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-05-07 | Tina Smith | sell | $100K – $250K |
| 2026-04-29 | Tina Smith | sell | $100K – $250K |